Cyril Amarchand Mangaldas advised the promoters of Suven Pharmaceuticals Limited on the deal. Global private equity firm Advent executed the acquisition of Suven Pharmaceuticals for an aggregate amount of...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here